Metabolic monitoring for patients on antipsychotic medication: are we failing to provide reasonable standard of physical healthcare?
- Department of Psychiatry, University of New South Wales, Sydney, Australia
- Correspondence to Valsamma Eapen
Department of Psychiatry, University of New South Wales, L1 Mental Health centre, Elizabeth Street, Sydney, NSW 2170, Australia;
Implications for practice and research
■ Patients with mental illness are vulnerable to weight gain and metabolic risk induced by antipsychotic medication, therefore, proactive monitoring and management are critical in improving outcomes.
■ Suboptimal metabolic monitoring even after the introduction of monitoring guidelines suggests the need for matching guidelines with appropriate training and quality assurance programmes.
■ There is a need to bridge the research gap through investigating the optimal methods of detecting, preventing and treating metabolic risk in mentally-ill patients; the implementation of effective monitoring methods is crucial.
■ An integrated evidence-based approach linking physical and mental health aspects using a shared care …